Feasibility of collecting social determinants of health data in the frontline pediatric acute lymphoblastic leukemia (ALL) trial AALL1731: A report from the Children's oncology group
Haley Newman(Children's Hospital of Philadelphia), Kira Bona(Dana-Farber Cancer Institute), Rahela Aziz‐Bose(Harvard University), Stephen P. Hunger(Children's Hospital of Philadelphia), Elizabeth A. Raetz(NYU Langone Health), Daniel J. Zheng(Children's Hospital of Philadelphia), John A. Kairalla(BC Children's Hospital), David T. Teachey(Children's Hospital of Philadelphia), Sarah Alexander(BC Children's Hospital), Rachel E. Rau(Seattle Children's Hospital), Peter D. Cole(Rutgers, The State University of New Jersey), Puja J. Umaretiya(The University of Texas Southwestern Medical Center), Sunyu Kang(Harvard University), Sumit Gupta(Dayanand Medical College & Hospital), Iris Paltin(Children's Hospital of Philadelphia), Meenakshi Devidas(National Institutes of Health), Paul Morgan(University of Pittsburgh), Colleen Kelly(Boston Children's Hospital), Cindy Wang(University of Florida), Mignon L. Loh(Seattle Children's Hospital)
Cited by 0
Related Papers
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
|New England Journal of Medicine|2013|3.4k